Range Low Price High Price Comment
30 days $17.56 $26.56 Wednesday, 27th Mar 2024 ACAD stock ended at $18.20. This is 2.30% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 2.65% from a day low at $17.73 to a day high of $18.20.
90 days $17.56 $31.92
52 weeks $17.56 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2020-11-06 $48.09 $50.50 $48.09 $50.19 965 127
2020-11-05 $46.40 $49.95 $46.13 $48.56 1 580 749
2020-11-04 $46.80 $50.08 $46.80 $49.13 1 849 002
2020-11-03 $45.36 $46.92 $45.36 $46.60 770 743
2020-11-02 $46.50 $46.56 $44.78 $45.64 787 863
2020-10-30 $46.80 $47.67 $45.35 $46.45 1 313 470
2020-10-29 $46.69 $48.00 $45.93 $47.35 1 006 191
2020-10-28 $45.90 $47.75 $45.32 $46.42 1 995 744
2020-10-27 $45.00 $47.55 $44.55 $46.36 2 199 587
2020-10-26 $42.90 $44.91 $42.90 $44.87 1 361 152
2020-10-23 $42.37 $43.33 $42.16 $43.17 920 947
2020-10-22 $41.02 $42.47 $41.02 $42.23 492 170
2020-10-21 $41.34 $41.59 $40.61 $41.04 527 890
2020-10-20 $41.49 $41.98 $40.38 $41.21 1 028 979
2020-10-19 $42.93 $43.47 $41.40 $41.49 745 605
2020-10-16 $42.56 $44.28 $42.50 $42.61 1 493 656
2020-10-15 $42.45 $43.19 $41.92 $42.71 697 909
2020-10-14 $43.79 $43.81 $42.90 $42.92 534 096
2020-10-13 $43.25 $43.65 $42.88 $43.26 413 239
2020-10-12 $43.19 $43.57 $42.57 $43.12 738 268
2020-10-09 $43.17 $43.30 $42.41 $42.73 547 234
2020-10-08 $43.21 $43.21 $42.16 $43.18 630 823
2020-10-07 $41.95 $43.15 $41.93 $42.89 718 476
2020-10-06 $42.20 $42.70 $41.48 $41.68 630 478
2020-10-05 $41.82 $42.40 $41.54 $42.14 1 161 965
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT